New guidelines for management of febrile seizures in Japan

Jun Natsume, Shin ichiro Hamano, Kuniaki Iyoda, Hideaki Kanemura, Masaya Kubota, Masakazu Mimaki, Shinichi Niijima, Takuya Tanabe, Harumi Yoshinaga, Noriko Kojimahara, Hirohumi Komaki, Kenji Sugai, Tokiko Fukuda, Yoshihiro Maegaki, Hideo Sugie

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

In 2015, the Japanese Society of Child Neurology released new guidelines for the management of febrile seizures, the first update of such guidelines since 1996. In 1988, the Conference on Febrile Convulsions in Japan published “Guidelines for the Treatment of Febrile Seizures.” The Task Committee of the Conference proposed a revised version of the guidelines in 1996; that version released in 1996 was used for the next 19 years in Japan for the clinical management of children with febrile seizures. Although the guidelines were very helpful for many clinicians, new guidelines were needed to reflect changes in public health and the dissemination of new medical evidence. The Japanese Society of Child Neurology formed a working group in 2012, and published the new guidelines in March 2015. The guidelines include emergency care, application of electroencephalography, neuroimaging, prophylactic diazepam, antipyretics, drugs needing special attention, and vaccines. While the new guidelines contain updated clinical recommendations, many unsolved questions remain. These questions should be clarified by future clinical research.

Original languageEnglish
Pages (from-to)2-9
Number of pages8
JournalBrain and Development
Volume39
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Febrile Seizures
Japan
Guidelines
Neurology
Antipyretics
Emergency Medical Services
Diazepam
Neuroimaging
Electroencephalography
Vaccines
Public Health

Keywords

  • Antihistamine
  • Antipyretics
  • Diazepam
  • Electroencephalogram
  • Lumbar puncture
  • Midazolam
  • Status epilepticus
  • Theophylline
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Natsume, J., Hamano, S. I., Iyoda, K., Kanemura, H., Kubota, M., Mimaki, M., ... Sugie, H. (2017). New guidelines for management of febrile seizures in Japan. Brain and Development, 39(1), 2-9. https://doi.org/10.1016/j.braindev.2016.06.003

New guidelines for management of febrile seizures in Japan. / Natsume, Jun; Hamano, Shin ichiro; Iyoda, Kuniaki; Kanemura, Hideaki; Kubota, Masaya; Mimaki, Masakazu; Niijima, Shinichi; Tanabe, Takuya; Yoshinaga, Harumi; Kojimahara, Noriko; Komaki, Hirohumi; Sugai, Kenji; Fukuda, Tokiko; Maegaki, Yoshihiro; Sugie, Hideo.

In: Brain and Development, Vol. 39, No. 1, 01.01.2017, p. 2-9.

Research output: Contribution to journalReview article

Natsume, J, Hamano, SI, Iyoda, K, Kanemura, H, Kubota, M, Mimaki, M, Niijima, S, Tanabe, T, Yoshinaga, H, Kojimahara, N, Komaki, H, Sugai, K, Fukuda, T, Maegaki, Y & Sugie, H 2017, 'New guidelines for management of febrile seizures in Japan', Brain and Development, vol. 39, no. 1, pp. 2-9. https://doi.org/10.1016/j.braindev.2016.06.003
Natsume J, Hamano SI, Iyoda K, Kanemura H, Kubota M, Mimaki M et al. New guidelines for management of febrile seizures in Japan. Brain and Development. 2017 Jan 1;39(1):2-9. https://doi.org/10.1016/j.braindev.2016.06.003
Natsume, Jun ; Hamano, Shin ichiro ; Iyoda, Kuniaki ; Kanemura, Hideaki ; Kubota, Masaya ; Mimaki, Masakazu ; Niijima, Shinichi ; Tanabe, Takuya ; Yoshinaga, Harumi ; Kojimahara, Noriko ; Komaki, Hirohumi ; Sugai, Kenji ; Fukuda, Tokiko ; Maegaki, Yoshihiro ; Sugie, Hideo. / New guidelines for management of febrile seizures in Japan. In: Brain and Development. 2017 ; Vol. 39, No. 1. pp. 2-9.
@article{610b50dd5eb047a88799ab5b89385cd9,
title = "New guidelines for management of febrile seizures in Japan",
abstract = "In 2015, the Japanese Society of Child Neurology released new guidelines for the management of febrile seizures, the first update of such guidelines since 1996. In 1988, the Conference on Febrile Convulsions in Japan published “Guidelines for the Treatment of Febrile Seizures.” The Task Committee of the Conference proposed a revised version of the guidelines in 1996; that version released in 1996 was used for the next 19 years in Japan for the clinical management of children with febrile seizures. Although the guidelines were very helpful for many clinicians, new guidelines were needed to reflect changes in public health and the dissemination of new medical evidence. The Japanese Society of Child Neurology formed a working group in 2012, and published the new guidelines in March 2015. The guidelines include emergency care, application of electroencephalography, neuroimaging, prophylactic diazepam, antipyretics, drugs needing special attention, and vaccines. While the new guidelines contain updated clinical recommendations, many unsolved questions remain. These questions should be clarified by future clinical research.",
keywords = "Antihistamine, Antipyretics, Diazepam, Electroencephalogram, Lumbar puncture, Midazolam, Status epilepticus, Theophylline, Vaccine",
author = "Jun Natsume and Hamano, {Shin ichiro} and Kuniaki Iyoda and Hideaki Kanemura and Masaya Kubota and Masakazu Mimaki and Shinichi Niijima and Takuya Tanabe and Harumi Yoshinaga and Noriko Kojimahara and Hirohumi Komaki and Kenji Sugai and Tokiko Fukuda and Yoshihiro Maegaki and Hideo Sugie",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.braindev.2016.06.003",
language = "English",
volume = "39",
pages = "2--9",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - New guidelines for management of febrile seizures in Japan

AU - Natsume, Jun

AU - Hamano, Shin ichiro

AU - Iyoda, Kuniaki

AU - Kanemura, Hideaki

AU - Kubota, Masaya

AU - Mimaki, Masakazu

AU - Niijima, Shinichi

AU - Tanabe, Takuya

AU - Yoshinaga, Harumi

AU - Kojimahara, Noriko

AU - Komaki, Hirohumi

AU - Sugai, Kenji

AU - Fukuda, Tokiko

AU - Maegaki, Yoshihiro

AU - Sugie, Hideo

PY - 2017/1/1

Y1 - 2017/1/1

N2 - In 2015, the Japanese Society of Child Neurology released new guidelines for the management of febrile seizures, the first update of such guidelines since 1996. In 1988, the Conference on Febrile Convulsions in Japan published “Guidelines for the Treatment of Febrile Seizures.” The Task Committee of the Conference proposed a revised version of the guidelines in 1996; that version released in 1996 was used for the next 19 years in Japan for the clinical management of children with febrile seizures. Although the guidelines were very helpful for many clinicians, new guidelines were needed to reflect changes in public health and the dissemination of new medical evidence. The Japanese Society of Child Neurology formed a working group in 2012, and published the new guidelines in March 2015. The guidelines include emergency care, application of electroencephalography, neuroimaging, prophylactic diazepam, antipyretics, drugs needing special attention, and vaccines. While the new guidelines contain updated clinical recommendations, many unsolved questions remain. These questions should be clarified by future clinical research.

AB - In 2015, the Japanese Society of Child Neurology released new guidelines for the management of febrile seizures, the first update of such guidelines since 1996. In 1988, the Conference on Febrile Convulsions in Japan published “Guidelines for the Treatment of Febrile Seizures.” The Task Committee of the Conference proposed a revised version of the guidelines in 1996; that version released in 1996 was used for the next 19 years in Japan for the clinical management of children with febrile seizures. Although the guidelines were very helpful for many clinicians, new guidelines were needed to reflect changes in public health and the dissemination of new medical evidence. The Japanese Society of Child Neurology formed a working group in 2012, and published the new guidelines in March 2015. The guidelines include emergency care, application of electroencephalography, neuroimaging, prophylactic diazepam, antipyretics, drugs needing special attention, and vaccines. While the new guidelines contain updated clinical recommendations, many unsolved questions remain. These questions should be clarified by future clinical research.

KW - Antihistamine

KW - Antipyretics

KW - Diazepam

KW - Electroencephalogram

KW - Lumbar puncture

KW - Midazolam

KW - Status epilepticus

KW - Theophylline

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84995476536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995476536&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2016.06.003

DO - 10.1016/j.braindev.2016.06.003

M3 - Review article

VL - 39

SP - 2

EP - 9

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

IS - 1

ER -